CGTX Cognition Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026
$0,93
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,5552 haftanın en düşüğü
$2,0552 haftanın en yükseği
Piyasa Değeri (MRQ)
$88M
P/E
-2.9
Hisse Başına Kâr
$-0.32
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$3
P/E
-2.9
ROE
-113.7%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CGTX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.93
Piyasa Değeri (MRQ)
$88M
P/E
-2.9
Hisse Başına Kâr
$-0.32
ROE
-113.7%
52 Haftlık Aralık
$1–$2
CGTX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-0.322020-12-31 → 2025-12-31
Serbest Nakit Akışı·2021-12-31 → 2024-12-31
Net kar marjı·2021-12-31 → 2023-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CGTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -2.95Y ort. ≈-2.3 | ≈-2.3 | · | · | |
| P/S (F/S) | -2937.35Y ort. ≈-2064.1 | ≈-2064.1 | · | · | |
| F/D (MRQ) | 2.75Y ort. ≈2.5 | ≈2.5 | 3.6 | Adil değer | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -3.35Y ort. ≈-10.4 | ≈-10.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 2.45Y ort. ≈2.5 | ≈2.5 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CGTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -59.8%5Y ort. ≈-59.7% | ≈-59.7% | -53.9% | Aynı seviyede | |
| ROE | -113.7%5Y ort. ≈-80.5% | ≈-80.5% | -94.1% | Ortalamanın altında |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CGTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 7.05Y ort. ≈4.6 | ≈4.6 | 3.2 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 2.65Y ort. ≈4.0 | ≈4.0 | 2.8 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
15.3%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.04 | $-0.06 | 38.1% |
| 31 Mart 2026 | May 13, 2026 | $-0.05 | $-0.07 | 27.4% |
| 31 Aralık 2025 | $-0.05 | $-0.09 | 43.5% | |
| 30 Eylül 2025 | $-0.06 | $-0.10 | 41.2% | |
| 30 Haziran 2025 | $-0.11 | $-0.11 | -1.1% | |
| 31 Mart 2025 | $-0.14 | $-0.11 | -24.4% | |
| 31 Aralık 2024 | $-0.17 | $-0.14 | -17.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $37M | $42M | $37M | $30M | $19M | $13M | |
| SG&A Expense | $11M | $12M | $14M | $13M | $10M | $5M | |
| Operating Expenses | $48M | $54M | $51M | $44M | $29M | $17M | |
| Operating Income | $-48M | $-54M | $-51M | $-44M | $-29M | $-17M | |
| Other Non-op | $24M | $20M | $25M | $22M | $17M | $10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-23M | $-34M | $-26M | $-21M | $-12M | $-8M | |
| EPS (Basic) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| EPS (Diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| Shares (Basic) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| Shares (Diluted) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| EBITDA | $-48M | $-54M | $-51M | $-43M | $-29M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $25M | $30M | $42M | $55M | $5M | |
| Prepaid Expense | $1M | $2M | $3M | $2M | $2M | $544.0K | |
| Other Current Assets | · | · | · | · | $11.0K | $23.0K | |
| Current Assets | $48M | $30M | $34M | $48M | $59M | $7M | |
| PP&E (Net) | $93.0K | $181.0K | $284.0K | $233.0K | $145.0K | $211.0K | |
| PP&E (Gross) | $280.0K | $1M | $1M | $1M | $1M | $988.0K | |
| Accum. Depreciation | $187.0K | $1M | $1M | $953.0K | $870.0K | $777.0K | |
| Total Assets | $48M | $30M | $35M | $50M | $59M | $7M | |
| Accounts Payable | $1M | $2M | $4M | $3M | $4M | $2M | |
| Accrued Liabilities | $12M | $8M | $4M | $2M | $2M | $994.0K | |
| Current Liabilities | $14M | $11M | $10M | $8M | $8M | $3M | |
| Capital Leases | $195.0K | $342.0K | $520.0K | $695.0K | · | · | |
| Deferred Tax | $67.0K | $110.0K | $147.0K | $178.0K | $13.0K | $22.0K | |
| Other Non-current Liabilities | · | · | $0 | $2M | $0 | · | |
| Total Liabilities | $14M | $11M | $11M | $10M | $8M | $20M | |
| Common Stock | $90.0K | $60.0K | $32.0K | $29.0K | $22.0K | $1.0K | |
| Paid-in Capital | $233M | $194M | $166M | $156M | $145M | $222.0K | |
| Retained Earnings | $-199M | $-175M | $-141M | $-115M | $-94M | $-68M | |
| AOCI | · | · | $-195.0K | $-199.0K | $-198.0K | $-187.0K | |
| Stockholders' Equity | $34M | $19M | $24M | $40M | $51M | $-68M | |
| Liabilities + Equity | $48M | $30M | $35M | $50M | $59M | $7M | |
| Shares Outstanding | 88,904,161 | 59,854,877 | 32,165,478 | 28,991,548 | 22,230,032 | 538,793 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $36.0K | $107.0K | $96.0K | $83.0K | $93.0K | $98.0K | |
| Stock-based Comp | $2M | $4M | $4M | $4M | $5M | $475.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | $-3M | $2M | $5M | $-791.0K | $3M | · | |
| Operating Cash Flow | $-25M | $-28M | $-16M | $-19M | $-4M | $-3M | |
| CapEx | · | $4.0K | $147.0K | $171.0K | $27.0K | $10.0K | |
| Investing Cash Flow | $9.0K | $-4.0K | $-147.0K | $-171.0K | $-27.0K | $-10.0K | |
| Financing Cash Flow | $37M | $24M | $5M | $6M | $53M | $6M | |
| Net Change in Cash | $12M | $-5M | $-12M | $-13M | $50M | $2M | |
| Free Cash Flow | · | $-28M | $-16M | $-19M | $-4M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 187866.7% | 155539.3% | 3202.5% | · | |
| Net Margin | · | · | 95511.1% | 76417.9% | 1312.0% | · | |
| EBITDA Margin | · | · | 187511.1% | 155242.9% | 3192.1% | · | |
| ROA | -59.8% | -103.9% | -60.3% | -39.1% | -35.4% | · | |
| ROE | -113.7% | -204.5% | -96.6% | -53.8% | 66.1% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 | · | |
| Quick Ratio | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | -0.0 | -0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.31 | $0.76 | $1.39 | $2.31 | · | |
| Revenue / Share | · | · | $-0.00 | $-0.00 | $-0.17 | · | |
| Cash Flow / Share | $-0.34 | $-0.72 | $-0.53 | $-0.78 | $-0.70 | · | |
| Cash / Share | $0.41 | $0.42 | $0.93 | $1.43 | $2.46 | · | |
| EPS (TTM) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | $-27.0K | $-28.0K | $-893.0K | · | |
| Net Income TTM | $-23M | $-34M | $-26M | $-21M | $-12M | · | |
| Market Cap | $120M | $42M | $60M | $61M | $140M | · | |
| P/E | -4.2 | -0.8 | -2.2 | -2.3 | -2.0 | · | |
| P/S | -4286.5 | -1498.5 | -2203.9 | -2174.4 | -157.3 | · | |
| P/B | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Tangible Book | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Cash Flow | -4.9 | -1.5 | -3.7 | -3.3 | -38.7 | · | |
| P / FCF | · | -1.5 | -3.7 | -3.3 | -38.4 | · | |
| Earnings Yield | -23.7% | -122.7% | -46.5% | -43.3% | -49.5% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $6M | $11M | $4M | $11M | $11M | $8M | $11M | $12M | $11M | $12M | $12M | $8M | $5M | $6M | $8M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $8M | $9M | $14M | $6M | $14M | $14M | $11M | $14M | $15M | $14M | $15M | $15M | $12M | $9M | $9M | $13M | |
| Operating Income | $-8M | $-9M | $-14M | $-6M | $-14M | $-14M | $-11M | $-14M | $-15M | $-14M | $-15M | $-15M | $-12M | $-9M | $-9M | $-13M | |
| Other Non-op | $4M | $4M | $10M | $1M | $7M | $5M | $3M | $5M | $8M | $5M | $7M | $8M | $7M | $3M | $4M | $6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $-6M | · | · | |
| Net Income | $-4M | $-5M | $-3M | $-5M | $-7M | $-8M | $-8M | $-10M | $-7M | $-9M | $-8M | $-7M | $-5M | $-6M | $-5M | $-7M | |
| EPS (Basic) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| EPS (Diluted) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| Shares (Basic) | 90,624,381 | 89,191,313 | · | 77,951,513 | 63,690,945 | 61,828,149 | · | 40,418,065 | 40,062,954 | 33,735,269 | · | 30,365,506 | 29,614,822 | 29,094,592 | · | 23,024,026 | |
| Shares (Diluted) | 90,624,381 | 89,191,313 | · | 77,951,513 | 63,690,945 | 61,828,149 | · | 40,418,065 | 40,062,954 | 33,735,269 | · | 30,365,506 | 29,614,822 | 29,094,592 | · | 23,024,026 | |
| EBITDA | $-8M | $-9M | · | $-6M | $-14M | $-14M | · | $-14M | $-15M | $-14M | · | $-15M | $-12M | $-9M | · | $-13M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $31M | $37M | $39M | $11M | $16M | $25M | $22M | $29M | $35M | $30M | $33M | $37M | $39M | $42M | $47M | |
| Prepaid Expense | $586.0K | $932.0K | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $2M | |
| Current Assets | $38M | $36M | $48M | $43M | $19M | $23M | $30M | $27M | $34M | $38M | $34M | $36M | $42M | $43M | $48M | $51M | |
| PP&E (Net) | $87.0K | $77.0K | $93.0K | $159.0K | $174.0K | $190.0K | $181.0K | $207.0K | $234.0K | $257.0K | $284.0K | $281.0K | $248.0K | $253.0K | $233.0K | $246.0K | |
| PP&E (Gross) | · | · | $280.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $187.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $953.0K | · | |
| Total Assets | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Accounts Payable | $673.0K | $4M | $1M | $827.0K | $771.0K | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $3M | $8M | |
| Accrued Liabilities | $4M | $2M | $12M | $4M | $9M | $8M | $8M | $10M | $6M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $5M | $6M | $14M | $7M | $12M | $11M | $11M | $13M | $11M | $10M | $10M | $8M | $8M | $7M | $8M | $12M | |
| Capital Leases | $422.0K | $176.0K | $195.0K | $212.0K | $229.0K | $280.0K | $342.0K | $392.0K | $440.0K | $488.0K | $520.0K | $565.0K | $608.0K | $651.0K | $695.0K | $603.0K | |
| Deferred Tax | · | · | $67.0K | · | · | · | $110.0K | · | · | · | $147.0K | · | · | · | $178.0K | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $1M | $1M | $2M | $2M | $2M | |
| Total Liabilities | $6M | $6M | $14M | $7M | $13M | $11M | $11M | $13M | $11M | $10M | $11M | $10M | $10M | $10M | $10M | $14M | |
| Common Stock | $95.0K | $90.0K | $90.0K | $88.0K | $65.0K | $62.0K | $60.0K | $41.0K | $40.0K | $40.0K | $32.0K | $30.0K | $30.0K | $29.0K | $29.0K | $24.0K | |
| Paid-in Capital | $240M | $233M | $233M | $232M | $197M | $196M | $194M | $182M | $180M | $179M | $166M | $162M | $161M | $158M | $156M | $150M | |
| Retained Earnings | $-207M | $-203M | $-199M | $-195M | $-190M | $-184M | $-175M | $-167M | $-157M | $-150M | $-141M | $-133M | $-126M | $-122M | $-115M | $-110M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-195.0K | $-196.0K | $-196.0K | $-195.0K | $-199.0K | $-201.0K | |
| Stockholders' Equity | $33M | $30M | $34M | $37M | $7M | $12M | $19M | $14M | $23M | $29M | $24M | $29M | $34M | $36M | $40M | $39M | |
| Liabilities + Equity | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Shares Outstanding | 95,055,773 | 89,353,773 | 88,904,161 | 88,268,078 | 64,962,957 | 61,974,755 | 59,854,877 | 40,806,092 | 40,112,268 | 39,985,866 | 32,165,478 | 30,417,082 | 30,286,582 | 29,277,227 | 28,991,548 | 23,969,497 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $14.0K | $15.0K | · | · | $27.0K | $27.0K | $26.0K | $27.0K | $27.0K | $25.0K | $23.0K | $21.0K | $23.0K | $22.0K | |
| Stock-based Comp | $319.0K | $330.0K | $358.0K | $522.0K | $621.0K | $586.0K | $534.0K | $896.0K | $1M | $1M | $1M | $1M | $1M | $1M | $902.0K | $777.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $709.0K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-3M | $-6M | $-6M | $-10M | $-8M | $-7M | $-6M | $-7M | $-5M | $-4M | $-4M | $-3M | $-10M | $-4.0K | |
| CapEx | · | · | · | · | · | · | $1.0K | $0 | · | · | $30.0K | $58.0K | $18.0K | $41.0K | $10.0K | $23.0K | |
| Investing Cash Flow | · | · | · | · | · | · | $-1.0K | $0 | · | · | $-30.0K | $-58.0K | $-18.0K | $-41.0K | $-10.0K | $-23.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $197.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $197.0K | · | · | |
| Financing Cash Flow | $7M | $-233.0K | $605.0K | $34M | $752.0K | $1M | $11M | $329.0K | $-138.0K | $12M | $2M | $-3.0K | $2M | $-10.0K | $5M | $869.0K | |
| Net Change in Cash | $4M | $-6M | $-3M | $28M | $-5M | $-9M | $3M | $-7M | $-6M | $5M | $-3M | $-4M | $-2M | $-3M | $-5M | $839.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | 141020.0% | · | 737250.0% | 196950.0% | 89730.0% | · | 631250.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | 91510.0% | · | 337450.0% | 78766.7% | 61720.0% | · | 331250.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | 78766.7% | 61720.0% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | 140750.0% | · | 737250.0% | 196950.0% | 89520.0% | · | 631250.0% | |
| ROA | -13.4% | -15.3% | · | -13.9% | -24.9% | -27.2% | · | -29.9% | -18.0% | -21.7% | · | -14.6% | -9.8% | -11.8% | · | -19.8% | |
| ROE | -19.6% | -21.7% | · | -19.3% | -44.8% | -41.2% | · | -45.8% | -24.5% | -28.3% | · | -19.8% | -12.1% | -14.6% | · | 28.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 5.9 | · | 6.4 | 1.5 | 2.1 | · | 2.1 | 3.1 | 4.0 | · | 4.4 | 5.3 | 5.7 | · | 4.2 | |
| Quick Ratio | 6.2 | 5.1 | · | 5.9 | 0.9 | 1.5 | · | 1.7 | 2.6 | 3.6 | · | 4.0 | 4.7 | 5.2 | · | 3.8 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | -0.0 | · | 0.0 | -0.0 | -0.0 | · | -0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $0.33 | · | $0.41 | $0.11 | $0.20 | · | $0.35 | $0.57 | $0.72 | · | $0.95 | $1.14 | $1.22 | · | $1.64 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $-0.00 | · | $-0.00 | $-0.00 | $-0.00 | · | $-0.00 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.16 | · | · | · | $-0.21 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.36 | $0.35 | · | $0.45 | $0.17 | $0.27 | · | $0.54 | $0.71 | $0.87 | · | $1.08 | $1.23 | $1.33 | · | $1.94 | |
| EPS (TTM) | $-0.16 | $-0.23 | · | $-0.47 | $-0.66 | $-0.73 | · | $-0.97 | $-0.94 | $-0.92 | · | $-0.79 | $-0.86 | $-0.95 | · | $10.69 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $-28.0K | $-28.0K | $-29.0K | · | $-17.0K | |
| Net Income TTM | $-17M | $-20M | · | $-28M | $-33M | $-33M | · | $-34M | $-31M | $-29M | · | $-23M | $-23M | $-24M | · | $-24M | |
| Market Cap | $109M | $68M | · | $119M | $20M | $26M | · | $19M | $67M | $73M | · | $44M | $55M | $58M | · | $46M | |
| P/E | -7.2 | -3.3 | · | -2.9 | -0.5 | -0.6 | · | -0.5 | -1.8 | -2.0 | · | -1.8 | -2.1 | -2.1 | · | 0.2 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | -1564.3 | -1979.4 | -1998.9 | · | -2678.9 | |
| P/B | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Tangible Book | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -12.3 | · | · | · | -2.6 | · | · | · | -10.0 | · | · | · | -21.4 | · | · | |
| Earnings Yield | -13.9% | -30.3% | · | -34.8% | -212.9% | -173.4% | · | -206.8% | -56.6% | -50.5% | · | -54.9% | -47.0% | -48.0% | · | 562.6% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı % | · | · | 187866.7% | 155539.3% | 3202.5% |
| Net Gelir | $-23M | $-34M | $-26M | $-21M | $-12M |
| Seyreltilmiş Hisse Başı Kâr | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 |
| Cari Oran | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | $-28M | $-16M | $-19M | $-4M |
Kurumsal Sahipler (13F) 69 dosya · $30.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
69
Tutulan Değer
$30.4M
Yeni pozisyonlar
3
Çıkan pozisyonlar
13
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 3 (-11 önceki Ç'ye göre) | 13 (+1 önceki Ç'ye göre) | 23 (+6 önceki Ç'ye göre) | 10 (-3 önceki Ç'ye göre) | +1.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BIOS Capital Management, LP | $6.900.001 | 6.000.000 | 22,71% | Hisse senetleri |
| DAVENPORT & Co LLC | $4.898.438 | 4.259.511 | 16,12% | Hisse senetleri |
| VANGUARD GROUP INC | $4.478.658 | 3.317.525 | 14,74% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.954.591 | 3.438.775 | 13,02% | Hisse senetleri |
| BlackRock, Inc. | $1.451.292 | 1.261.993 | 4,78% | Hisse senetleri |
| Chescapmanager LLC | $1.146.583 | 997.029 | 3,77% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.047.051 | 910.006 | 3,45% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $797.281 | 693.288 | 2,62% | Hisse senetleri |
| Hilton Capital Management, LLC | $631.293 | 548.950 | 2,08% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $584.453 | 508.220 | 1,92% | Hisse senetleri |
| CM Management, LLC | $517.500 | 450.000 | 1,70% | Hisse senetleri |
| Dauntless Investment Group, LLC | $427.456 | 371.701 | 1,41% | Hisse senetleri |
| Sigma Planning Corp | $416.605 | 362.265 | 1,37% | Hisse senetleri |
| STATE STREET CORP | $401.330 | 348.983 | 1,32% | Hisse senetleri |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $368.575 | 320.500 | 1,21% | Hisse senetleri |
| UBS Group AG | $251.316 | 218.536 | 0,83% | Hisse senetleri |
| AMERICAN FINANCIAL GROUP INC | $235.750 | 205.000 | 0,78% | Hisse senetleri |
| NORTHERN TRUST CORP | $204.932 | 178.202 | 0,67% | Hisse senetleri |
| Voss Capital, LP | $201.250 | 175.000 | 0,66% | Hisse senetleri |
| Texas Capital Bank Wealth Management Services Inc | $164.790 | 143.296 | 0,54% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97.681 | 84.940 | 0,32% | Hisse senetleri |
| XTX Topco Ltd | $90.242 | 78.471 | 0,30% | Hisse senetleri |
| Corient Private Wealth LP | $89.960 | 78.226 | 0,30% | Hisse senetleri |
| McAdam, LLC | $74.236 | 64.553 | 0,24% | Hisse senetleri |
| FCA CORP /TX | $60.416 | 52.536 | 0,20% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $58.478 | 50.850 | 0,19% | Hisse senetleri |
| Circle Wealth Management, LLC | $56.168 | 48.842 | 0,18% | Hisse senetleri |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $55.200 | 48.000 | 0,18% | Hisse senetleri |
| Bangor Savings Bank | $46.597 | 40.519 | 0,15% | Hisse senetleri |
| Essex Financial Services, Inc. | $46.000 | 40.000 | 0,15% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $45.521 | 40.644 | 0,15% | Hisse senetleri |
| GABELLI FUNDS LLC | $34.500 | 30.000 | 0,11% | Hisse senetleri |
| Bryn Mawr Trust Advisors, LLC | $33.408 | 29.050 | 0,11% | Hisse senetleri |
| MORGAN STANLEY | $32.054 | 27.873 | 0,11% | Hisse senetleri |
| HighTower Advisors, LLC | $30.475 | 26.500 | 0,10% | Hisse senetleri |
| PRIVATE MANAGEMENT GROUP INC | $27.600 | 24.000 | 0,09% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $27.187 | 23.641 | 0,09% | Hisse senetleri |
| CWA Asset Management Group, LLC | $26.450 | 23.000 | 0,09% | Hisse senetleri |
| Creative Planning | $25.530 | 22.200 | 0,08% | Hisse senetleri |
| Qube Research & Technologies Ltd | $25.070 | 21.800 | 0,08% | Hisse senetleri |
| GAMCO INVESTORS, INC. ET AL | $23.000 | 20.000 | 0,08% | Hisse senetleri |
| Cetera Investment Advisers | $22.828 | 19.850 | 0,08% | Hisse senetleri |
| Rockefeller Capital Management L.P. | $22.116 | 19.231 | 0,07% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $20.087 | 17.467 | 0,07% | Hisse senetleri |
| Focus Partners Wealth | $19.838 | 17.250 | 0,07% | Hisse senetleri |
| Northeast Financial Consultants Inc | $19.627 | 63.351 | 0,06% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $18.344 | 15.951 | 0,06% | Hisse senetleri |
| CITIZENS FINANCIAL GROUP INC/RI | $15.731 | 13.679 | 0,05% | Hisse senetleri |
| Bank of New York Mellon Corp | $15.481 | 13.462 | 0,05% | Hisse senetleri |
| BRADLEY FOSTER & SARGENT INC/CT | $13.480 | 11.722 | 0,04% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| BIOS MEMORY SPV I, LP, BIOS MEMORY SPV II, LP, BIOS FUND I, LP, BIOS FUND I QP, LP, BP DIRECTORS, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BIOS FUND III, LP, BIOS FUND III QP, LP, BIOS FUND III NT, LP, BIOS CLINICAL OPPORTUNITY FUND, LP, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS EQUITY PARTNERS III, LP, BIOS EQUITY COF, LP, CAVU MANAGEMENT, LP, BIOS CAPITAL MANAGEMENT, LP, CAVU ADVISORS, LLC, BIOS ADVISORS GP, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×5 başvurular | 23 Eylül 2025 | 6,80% | Değişiklik | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 13 içeriden öğrenenler · 4 yöneticiler · 7 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Lisa Ricciardi | CEO & President | 16 Nisan 2026 P | 1.715.851 | 1 | 0 | $10.092 |
| John Brendan Doyle | Chief Financial Officer | 01 Mayıs 2026 F | 618.942 | 1 | 0 | $11.300 |
| James Michael O'Brien | Chief Financial Officer | 23 Mart 2022 A | 5.000 | 0 | 0 | $0 |
| Anthony Caggiano | Chief Medical Officer | 16 Nisan 2026 P | 874.906 | 1 | 0 | $11.100 |
| Peggy Wallace | Yönetim kurulu üyesi | 17 Haziran 2026 A | 111.461 | 0 | 0 | $0 |
| Jack A. Khattar | Yönetim kurulu üyesi | 17 Haziran 2026 A | 73.500 | 0 | 0 | $0 |
| Brett P Monia | Yönetim kurulu üyesi | 17 Haziran 2026 A | 73.500 | 0 | 0 | $0 |
| Ellen B Richstone | Yönetim kurulu üyesi | 17 Haziran 2026 A | 83.500 | 0 | 0 | $0 |
| Fletcher Aaron G.L. | Yönetim kurulu üyesi | 19 Eylül 2025 M | 56.229 | 0 | 0 | $0 |
| Mark H. Breedlove | Yönetim kurulu üyesi | 13 Ekim 2021 X | 404.439 | 0 | 0 | $0 |
| Golden Seeds Cognition Therapeutics LLC | 10% sahip | 27 Eylül 2022 J | 0 | 0 | 0 | $0 |
| Ogden CAP Associates, LLC | 10% sahip | 13 Ekim 2021 X | 2.210.377 | 0 | 0 | $0 |
| BIOS MEMORY SPV I, LP | 10% sahip | 13 Ekim 2021 C | 60.065 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 4 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
CGTX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$3.00
+224,3%
2 22,2%
Güçlü Al
6 66,7%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-03Ortalama hedef $3.33 +260,3%
← Tüm hedeflerin altında
Mevcut fiyat $0.93
Düşük$3.00
Ortalama$3.33
Yüksek$4.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CGTX | $120M | -4.2 | · | · | -113.7% | · |
| PLYX | · | · | · | · | -193.7% | · |
| NMRA | $312M | -1.2 | · | · | -165.2% | · |
| NTRB | · | · | · | · | · | · |
| NTHI | · | -2.6 | -51.8% | · | · | · |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | · |
| TELO | $46M | -4.0 | · | · | -325.7% | · |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| CING | · | · | · | · | · | · |
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| ELOX | · | · | · | · | 30.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 7, 2026